ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Alterity Therapeutics Ltd

Alterity Therapeutics Ltd (ATH)

0,009
0,00
(0,00%)
Geschlossen 06 Juni 8:00AM

Alterity Therapeutics Ltd (ATH) Aktie

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
0,009
( - )
Gebot
0,008
Fragen
0,009
Volumen
0,00
0,00 Tagesbereich 0,00
0,007 52-Wochen-Bereich 0,0175
Marktkapitalisierung
Handelsende
0,009
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
AUD 5.191.988
Ausgegebene Aktien
217.508.326
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-5,45
Gewinn pro Aktie (EPS)
-0
Erlöse (LTM)
6,64M
Nettogewinn (LTM)
-14,59M

Über Alterity Therapeutics Ltd

Alterity Therapeutics Limited is engages in research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson’s disease. The company’s lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase II clinical tri... Alterity Therapeutics Limited is engages in research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson’s disease. The company’s lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase II clinical trial for the treatment of Parkinson’s disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; and ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy, as well as biomarkers of progression in multiple system atrophy. The company also operates drug discovery platform that generates patentable chemical compounds to treat the underlying pathology of neurological diseases. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is based in Melbourne, Australia. Mehr anzeigen

Sektor
Healthcare
Branche
Biotechnology & Life Sciences
Hauptsitz
Melbourne, Australia
Gegründet
1997
Alterity Therapeutics Ltd is listed in the Healthcare sector of the Australische Börse with ticker ATH. The last closing price for Alterity Therapeutics was AUD0,01. Over the last year, Alterity Therapeutics shares have traded in a share price range of AUD 0,007 to AUD 0,0175.

Alterity Therapeutics currently has 217.508.326 shares in issue. The market capitalisation of Alterity Therapeutics is AUD1,96 million. Alterity Therapeutics has a price to earnings ratio (PE ratio) of -5.45.

ATH Neueste Nachrichten

Keine Nachrichten vorhanden.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1000.0090.0090.00828576370.00889804DE
4-0.001-100.010.0110.00848359810.00955511DE
120.00112.50.0080.0110.00745430250.00951214DE
26-0.001-100.010.0110.00740844220.00872339DE
52-0.003-250.0120.01750.00785981910.01109853DE
1560.00228.57142857140.0070.0190.002105891980.00863667DE
260-0.02-68.96551724140.0290.0420.00279222920.01173786DE

ATH - Frequently Asked Questions (FAQ)

What is the current Alterity Therapeutics Ltd share price?
The current share price of Alterity Therapeutics Ltd is AUD 0,009
How many Alterity Therapeutics Ltd shares are in issue?
Alterity Therapeutics Ltd has 217.508.326 shares in issue
What is the market cap of Alterity Therapeutics Ltd?
The market capitalisation of Alterity Therapeutics Ltd is AUD 1,96M
What is the 1 year trading range for Alterity Therapeutics Ltd share price?
Alterity Therapeutics Ltd has traded in the range of AUD 0,007 to AUD 0,0175 during the past year
What is the PE ratio of Alterity Therapeutics Ltd?
The price to earnings ratio of Alterity Therapeutics Ltd is -5,45
What is the cash to sales ratio of Alterity Therapeutics Ltd?
The cash to sales ratio of Alterity Therapeutics Ltd is 14,75
What is the registered address of Alterity Therapeutics Ltd?
The registered address for Alterity Therapeutics Ltd is 350 Collins Street, Melbourne, Victoria, 3000
What is the Alterity Therapeutics Ltd website address?
The website address for Alterity Therapeutics Ltd is alteritytherapeutics.com
Which industry sector does Alterity Therapeutics Ltd operate in?
Alterity Therapeutics Ltd operates in the Biotechnology & Life Sciences sector

ATH Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen